Top

Published in:

01-11-2021 | Peritoneal Surface Malignancy

Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without HIPEC

Authors: Ankit Dhiman, MBBS, MS, Emily Fenton, BA, PA-C, Jeffrey Whitridge, RD, Jennifer Belanski, RN, Whitney Petersen, BA, PA-C, Sarah Macaraeg, PT, Govind Rangrass, MD, Ardaman Shergill, MD, Dejan Micic, MD, Oliver S. Eng, MD, Kiran Turaga, MD, MPH

Published in: Annals of Surgical Oncology | Issue 12/2021

Abstract

ERAS protocols may reduce length of stay and return to full functional recovery after cytoreductive surgery and HIPEC. Prehabilitation programs and post-operative goal directed pathways, along with other essential components of ERAS are discussed with supporting evidence.

Available only for authorised users

Foster JM, Sleightholm R, Patel A, et al. Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures. JAMA Netw Open. 2019;2(1):e186847. https://doi.org/10.1001/jamanetworkopen.2018.6847.CrossRefPubMedPubMedCentral

Spiliotis J, Halkia E, de Bree E. Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy—current perspectives. Curr Oncol. 2016;23(3):e266–75. https://doi.org/10.3747/co.23.2831.CrossRefPubMedPubMedCentral

Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery a review. JAMA Surg. 2017;152(3):292–8. https://doi.org/10.1001/jamasurg.2016.4952.CrossRefPubMed

Zhang X, Yang J, Chen X, Du L, Li K, Zhou Y. Enhanced recovery after surgery on multiple clinical outcomes: umbrella review of systematic reviews and meta-analyses. Medicine (Baltimore). 2020;99(29):e20983. https://doi.org/10.1097/MD.0000000000020983.CrossRefPubMedPubMedCentral

Nelson G, Kiyang LN, Crumley ET, et al. Implementation of enhanced recovery after surgery (ERAS) across a provincial healthcare system: the ERAS Alberta colorectal surgery experience. World J Surg. 2016;40(5):1092–103. https://doi.org/10.1007/s00268-016-3472-7.CrossRefPubMed

Webb C, Day R, Velazco CS, et al. Implementation of an Enhanced Recovery After Surgery (ERAS) program is associated with improved outcomes in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2020;27(1):303–12. https://doi.org/10.1245/s10434-019-07900-z.CrossRefPubMed

Lu PW, Fields AC, Shabat G, et al. Cytoreductive surgery and HIPEC in an enhanced recovery after surgery program: a feasibility study. J Surg Res. 2020;247:59–65. https://doi.org/10.1016/j.jss.2019.10.042.CrossRefPubMed

Siddharthan R, Dewey E, Billingsley K, Gilbert E, Tsikitis VL. Feasibility and benefits of an enhanced recovery after surgery protocol for patients undergoing cytoreductive surgery and heated intraperitoneal chemotharpy: a single institution experience. Am J Surg. 2020;219(6):1073–5. https://doi.org/10.1016/j.amjsurg.2019.06.019.CrossRefPubMed

Duzgun O. Evaluation of enhanced recovery after following a surgical protocol for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Med Arch (Sarajevo, Bosnia Herzegovina). 2019;73(5):331–7. https://doi.org/10.5455/medarh.2019.73.331-337.CrossRefPubMedCentral

10.

Martin RC, Marshall BM, Philips P, Egger M, McMasters KM, Scoggins CR. Enhanced recovery after surgery is safe for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Am J Surg. 2020;220(6):1428–32. https://doi.org/10.1016/j.amjsurg.2020.08.041.CrossRefPubMed

11.

Maciver AH, Al-Sukhni E, Esquivel J, Skitzki JJ, Kane JM, Francescutti VA. Current Delivery of hyperthermic intraperitoneal chemotherapy with cytoreductive surgery (CS/HIPEC) and perioperative practices: an international survey of high-volume surgeons. Ann Surg Oncol. 2017;24(4):923–30. https://doi.org/10.1245/s10434-016-5692-3.CrossRefPubMed

12.

Eng OS, Blakely AM, Lafaro KJ, et al. Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: an opportunity for enhanced recovery pathways. J Surg Oncol. 2020;122(5):980–5. https://doi.org/10.1002/jso.26099.CrossRefPubMed

13.

Hübner M, Kusamura S, Villeneuve L, et al. Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS®) Society recommendations—part I: preoperative and intraoperative management. Eur J Surg Oncol. 2020;46(12):2292–310. https://doi.org/10.1016/j.ejso.2020.07.041.CrossRefPubMed

14.

Hübner M, Kusamura S, Villeneuve L, et al. Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS®) Society recommendations—part II: postoperative management and special considerati. Eur J Surg Oncol. 2020;46(12):2311–23. https://doi.org/10.1016/j.ejso.2020.08.006.CrossRefPubMed

15.

Abola RE, Bennett-Guerrero E, Kent ML, et al. American society for enhanced recovery and perioperative quality initiative joint consensus statement on patient-reported outcomes in an enhanced recovery pathway. Anesth Analg. 2018;126(6):1874–82. https://doi.org/10.1213/ANE.0000000000002758.CrossRefPubMed

16.

Aloia TA, Zimmitti G, Conrad C, Gottumukalla V, Kopetz S, Vauthey JN. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol. 2014;110(2):107–14. https://doi.org/10.1002/jso.23626.CrossRefPubMedPubMedCentral

17.

Biagi JJ, Raphael MJ, Mackillop WJ, Kong W, King WD, Booth CM. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer a systematic review and meta-analysis. JAMA. 2011;305(22):2335–42. https://doi.org/10.1001/jama.2011.749.CrossRefPubMed

18.

Manso M, Schmelz J, Aloia T. ERAS—anticipated outcomes and realistic goals. J Surg Oncol. 2017;116(5):570–7. https://doi.org/10.1002/jso.24791.CrossRefPubMed

19.

Elias KM, Stone AB, McGinigle K, et al. The reporting on ERAS compliance, outcomes, and elements research (RECOvER) checklist: a joint statement by the ERAS® and ERAS® USA societies. World J Surg. 2019;43(1):1–8. https://doi.org/10.1007/s00268-018-4753-0.CrossRefPubMed

20.

Ni X, Jia D, Guo Y, Sun X, Suo J. The efficacy and safety of enhanced recovery after surgery (ERAS) program in laparoscopic digestive system surgery: a meta-analysis of randomized controlled trials. Int J Surg. 2019;69(July):108–15. https://doi.org/10.1016/j.ijsu.2019.07.034.CrossRefPubMed

21.

Luther A, Gabriel J, Watson RP, Francis NK. The impact of total body prehabilitation on post-operative outcomes after major abdominal surgery: a systematic review. World J Surg. 2018;42(9):2781–91. https://doi.org/10.1007/s00268-018-4569-y.CrossRefPubMed

22.

Cortés-Guiral D, Mohamed F, Glehen O, Passot G. Prehabilitation of patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancy. Eur J Surg Oncol. 2020;47:60–4. https://doi.org/10.1016/j.ejso.2020.01.032.CrossRefPubMed

23.

Reece L, Dragicevich H, Lewis C, et al. Preoperative nutrition status and postoperative outcomes in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2019;26(8):2622–30. https://doi.org/10.1245/s10434-019-07415-7.CrossRefPubMed

24.

Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11–48. https://doi.org/10.1016/j.clnu.2016.07.015.CrossRefPubMed

25.

McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of critical care medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (ASPEN). J Parenter Enter Nutr. 2016;40(2):159–211. https://doi.org/10.1177/0148607115621863.CrossRef

26.

Achilli P, Mazzola M, Bertoglio CL, et al. Preoperative immunonutrition in frail patients with colorectal cancer: an intervention to improve postoperative outcomes. Int J Colorectal Dis. 2020;35(1):19–27. https://doi.org/10.1007/s00384-019-03438-4.CrossRefPubMed

27.

Moaven O, Votanopoulos KI, Shen P, et al. Health-related quality of life after cytoreductive surgery/HIPEC for mucinous appendiceal cancer: results of a multicenter randomized trial comparing oxaliplatin and mitomycin. Ann Surg Oncol. 2020;27(3):772–80. https://doi.org/10.1245/s10434-019-08064-6.CrossRefPubMed

28.

Alverdy JC, Hyman N. Bowel preparation under siege. Br J Surg. 2020;107(3):167–70. https://doi.org/10.1002/bjs.11454.CrossRefPubMed

29.

Sarin A, Chen LL, Wick EC. Enhanced recovery after surgery—preoperative fasting and glucose loading—a review. J Surg Oncol. 2017;116(5):578–82. https://doi.org/10.1002/jso.24810.CrossRefPubMed

30.

Rizvanović N, Nesek Adam V, Čaušević S, Dervišević S, Delibegović S. A randomised controlled study of preoperative oral carbohydrate loading versus fasting in patients undergoing colorectal surgery. Int J Colorectal Dis. 2019;34(9):1551–61. https://doi.org/10.1007/s00384-019-03349-4.CrossRefPubMed

31.

Verret M, Lauzier F, Zarychanski R, et al. Perioperative use of gabapentinoids for the management of postoperative acute pain: a systematic review and meta-analysis. Anesthesiology. 2020;133(2):265–79. https://doi.org/10.1097/ALN.0000000000003428.CrossRefPubMed

32.

Güldner A, Kiss T, Serpa Neto A, et al. Intraoperative protective mechanical ventilation for prevention of postoperative pulmonary complications. Anesthesiology. 2015;123(3):692–713. https://doi.org/10.1097/aln.0000000000000754.CrossRefPubMed

33.

Hedenstierna G. Small tidal volumes, positive end-expiratory pressure, and lung recruitment maneuvers during anesthesia: good or bad? Anesthesiology. 2015;123(3):501–3. https://doi.org/10.1097/ALN.0000000000000755.CrossRefPubMed

34.

Briel M, Meade M, Mercat A. Higher vs lower positive end-expiratory pressure in patients with acute lung injury. JAMA J Am Med Assoc. 2010;303(9):865–73.CrossRef

35.

Eng OS, Dumitra S, O’Leary M, et al. Association of fluid administration with morbidity in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. JAMA Surg. 2017;152(12):1156–60. https://doi.org/10.1001/jamasurg.2017.2865.CrossRefPubMedPubMedCentral

36.

Colantonio L, Claroni C, Fabrizi L, et al. A randomized trial of goal directed vs standard fluid therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Gastrointest Surg. 2015;19(4):722–9. https://doi.org/10.1007/s11605-015-2743-1.CrossRefPubMed

37.

Pour-Ghaz I, Manolukas T, Foray N, et al. Accuracy of non-invasive and minimally invasive hemodynamic monitoring: where do we stand? Ann Transl Med. 2019;7(17):421–421. https://doi.org/10.21037/atm.2019.07.06.CrossRefPubMedPubMedCentral

38.

Rottenstreich A, Kalish Y, Kleinstern G, Ben YA, Dux J, Nissan A. Factors associated with thromboembolic events following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2017;116(7):914–20. https://doi.org/10.1002/jso.24746.CrossRefPubMed

39.

Vukadinovic V, Chiou JD, Morris DL. Clinical features of pulmonary emboli in patients following cytoreductive surgery (peritonectomy) and hyperthermic intraperitoneal chemotherapy (HIPEC), a single centre experience. Eur J Surg Oncol. 2015;41(5):702–6. https://doi.org/10.1016/j.ejso.2015.01.016.CrossRefPubMed

40.

McLeod RS, Aarts MA, Chung F, et al. Development of an enhanced recovery after surgery guideline and implementation strategy based on the knowledge-to-action cycle. Ann Surg. 2015;262(6):1016–25. https://doi.org/10.1097/SLA.0000000000001067.CrossRefPubMed

Title: Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without HIPEC
Authors: Ankit Dhiman, MBBS, MS
Emily Fenton, BA, PA-C
Jeffrey Whitridge, RD
Jennifer Belanski, RN
Whitney Petersen, BA, PA-C
Sarah Macaraeg, PT
Govind Rangrass, MD
Ardaman Shergill, MD
Dejan Micic, MD
Oliver S. Eng, MD
Kiran Turaga, MD, MPH
Publication date: 01-11-2021
Publisher: Springer International Publishing
Published in: Annals of Surgical Oncology / Issue 12/2021
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-021-09973-1

2024 ASCO Annual Meeting

Springer Medicine

Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without HIPEC

Abstract

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2021

Blood Vessel Invasion Predicts Postoperative Survival Outcomes and Systemic Recurrence Regardless of Location or Blood Vessel Type in Patients with Lung Adenocarcinoma

ASO Author Reflections: Survival Outcomes between Patients with Hypermetabolic Non-small Cell Lung Cancer Undergoing Systematic and Lobe-Specific Mediastinal Lymph Node Dissection

Serum α-Fetoprotein Levels at Time of Recurrence Predict Post-Recurrence Outcomes Following Resection of Hepatocellular Carcinoma

Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: Head and Neck Cancer

A Near-Zero Anastomotic Leak Rate in Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy is Achievable

ASO Author Reflections: Nationwide Data on Ostomy Use in Elderly Patients After Colorectal Cancer Surgery